Thermo Fisher Scientific (TMO) : Graybill Bartz Assoc Ltd scooped up 130 additional shares in Thermo Fisher Scientific during the most recent quarter end , according to a recent disclosure to the SEC on Apr 5, 2016. The investment management firm now holds a total of 26,970 shares of Thermo Fisher Scientific which is valued at $3.8 Million.Thermo Fisher Scientific makes up approximately 3.50% of Graybill Bartz Assoc Ltd’s portfolio.
Other Hedge Funds, Including , First American Trust Fsb boosted its stake in TMO in the latest quarter, The investment management firm added 290 additional shares and now holds a total of 19,527 shares of Thermo Fisher Scientific which is valued at $2.8 Million. Thermo Fisher Scientific makes up approx 0.98% of First American Trust Fsb’s portfolio.Renaissance Investment Group reduced its stake in TMO by selling 260 shares or 0.5% in the most recent quarter. The Hedge Fund company now holds 51,295 shares of TMO which is valued at $7.3 Million. Thermo Fisher Scientific makes up approx 3.66% of Renaissance Investment Group’s portfolio.
On the company’s financial health, Thermo Fisher Scientific reported $2.12 EPS for the quarter, beating the analyst consensus estimate by $ 0.01 according to the earnings call on Jan 28, 2016. Analyst had a consensus of $2.11. The company had revenue of $4652.50 million for the quarter, compared to analysts expectations of $4551.79 million. The company’s revenue was up 3.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.99 EPS.
Many Wall Street Analysts have commented on Thermo Fisher Scientific. Company shares were Reiterated by Mizuho on Apr 4, 2016 to “Buy”, Firm has raised the Price Target to $ 160 from a previous price target of $150 .Company shares were Reiterated by Topeka Capital Markets on Mar 2, 2016 to “Buy”, Firm has raised the Price Target to $ 155 from a previous price target of $145 .Company shares were Reiterated by Stifel on Jan 11, 2016 to “Buy”, Firm has raised the Price Target to $ 158 from a previous price target of $150 .
Thermo Fisher Scientific closed down -0.55 points or -0.39% at $141.66 with 9,22,626 shares getting traded on Monday. Post opening the session at $142.51, the shares hit an intraday low of $141.45 and an intraday high of $143.26 and the price fluctuated in this range throughout the day.Shares ended Monday session in Red.
Thermo Fisher Scientific Inc. is a provider of analytical instruments equipment reagents and consumables software and services for research manufacturing analysis discovery and diagnostics. The company operates through four segments: Life Sciences Solutions provides reagents instruments and consumables used in biological and medical research discovery and production of new drugs and vaccines as well as diagnosis of disease; Analytical Instruments provides instruments consumables software and services that are used in the laboratory; Specialty Diagnostics offers diagnostic test kits reagents culture media instruments and associated products and Laboratory Products and Services offers self-manufactured and sourced products for the laboratory.